semaglutide criteria for use Wegovy® (semaglutide) Prior Authorization & Form Dosing & Prescribing | RYBELSUS®

Liraglutide was approved in 2020 for use alongside lifestyle changes in pediatric patients 12 or older with a body weight over 60 kg (132 lbs.) and an initial BMI over 30

Average: 5 to 7 percent body weight loss (11 to 18 pounds for a 220-pound starting weight)

Optimal ranges: Men under 14 U/L Women under 9 U/L GGT tends to improve on GLP-1 therapy as metabolic health improves

By week 20, the cumulative incidence of first-time gastrointestinal adverse events plateaus

How Virtual Weight Loss Care Works 1

Since GLP-1 medications are known to reduce gut motility, scientists have wondered whether they could play a role in causing SIBO or IMO